Company Search:
Advanced Search
Sponsored Links
Arcturus Therapeutics Ltd Company Snapshot
Arcturus Therapeutics Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arcturus Therapeutics Ltd with three other companies in this sector in Israel: Redhill Biopharma Ltd (2017 sales of 14.31 million Israel Shekels [US$3.92 million] ), Clal Biotechnology Industries Limited (54.50 million Israel Shekels [US$14.93 million] of which 238% was Kayortech), and Evogene Limited (12.07 million Israel Shekels [US$3.31 million] of which 96% was Agricultural Crops).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arcturus Therapeutics Ltd
  Stock Performance Chart for Arcturus Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 17.94
(Figures in Israel Shekels)
1 Week -6.2%   13 Weeks -3.2%  
4 Weeks -28.8%   52 Weeks -12.4%  
Arcturus Therapeutics Ltd Key Data:
  Ticker: ARCT Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 46,416,508
(Year Ending Jan 2018).
Employees: N/A
  Currency: Israel Shekels Market Cap: 192,268,058
  Fiscal Yr Ends: December Shares Outstanding: 10,718,000
  Share Type: Common Closely Held Shares: 3,962,485
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.